Published in The Lancet · View the paper (DOI)
Widespread newborn screening for severe combined immunodeficiency (SCID) has increased the five-year survival rate from 73% to 87%, with 92.5% of children surviving five years or more after treatment. The study, led by NIAID, demonstrates that early identification and prompt treatment have saved countless lives.
Coverage from 2 institutions